4.2 Article

Vitamin D, neurocognitive functioning and immunocompetence

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/MCO.0b013e3283414c38

关键词

25-hydroxyvitamin D; Alzheimer's disease; depression; immunomodulator; muscle function; neurocognitive function; vitamin D

资金

  1. NIH [1UL1RR025771]
  2. UV Foundation
  3. NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025771] Funding Source: NIH RePORTER

向作者/读者索取更多资源

Purpose of review Vitamin D deficiency is recognized as one of the most common medical conditions in children and adults. The major causes are inadequate sun exposure and inadequate intakes of dietary and supplemental vitamin D. Vitamin D deficiency and insufficiency defined as a 25-hydroxyvitamin D level less than 20 and 21-29 ng/ml, respectively, have been linked to increased risk for a variety of medical conditions including cancer, heart disease, type II diabetes, infectious diseases, autoimmune diseases, metabolic bone diseases and neurological disorders. Recent findings The skeletal muscle and brain have a vitamin D receptor and the central nervous system has a capacity to activate vitamin D. Low vitamin D status has been linked to poor performance in neurocognitive testing in elderly. Vitamin D deficiency has been associated with muscle weakness, depression, schizophrenia, Alzheimer's disease, multiple sclerosis and a lower motor neuron-induced muscle atrophy. Summary Correcting vitamin D deficiency and preventing vitamin D deficiency in children and adults should be a high priority for healthcare professionals to reduce risk for a wide variety of neurological disorders. Children and adults should take at least 400 international unit IU and 2000 IU vitamin D/day, respectively, to prevent vitamin D deficiency and insufficiency.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据